Clinical Trials

Diabetes & Endocrine System Clinical Trials

10
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients with Type I Diabetes
Disease/Condition: Type 1 Diabetes
Principal Investigator: Kevan Herold
Effect of a Medium Chain Triglyceride Supplemented Diet on Cognitive Function and Brain Activation in Type 1 Diabetes.
Disease/Condition: Hypo-unawareness | Type 1 Diabetes
Principal Investigator: Robert Sherwin
Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.
Disease/Condition: Type 1 Diabetes
Principal Investigator: Robert Sherwin
Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia
Disease/Condition: Hypoglycemia
Principal Investigator: Robert Sherwin
Glycemic Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE Study)
Disease/Condition: Diabetes Mellitus Type 2
Principal Investigator: William Tamborlane
Investigation Into Effects Upon Counterregulatory Responses to Hypoglycemia During Intensive Treatment of T1DM
Disease/Condition: Hypoglycemia | Type 1 Diabetes
Principal Investigator: Robert Sherwin
Natural History Study of the Development of Type 1 Diabetes
Disease/Condition: Diabetes Mellitus, Type 1
Principal Investigator: Kevan Herold
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Disease/Condition: Diabetes Mellitus, Type 1
Principal Investigator: Kevan Herold
Prevalence of Carbohydrate Intolerance in Lean and Obese Children
Disease/Condition: Acanthosis Nigricans | Diabetes | Glucose Intolerance | Obesity
Principal Investigator: Sonia Caprio
Stress Management Among Latinos With Type 2 Diabetes
Disease/Condition: Diabetes Mellitus, Type 2
Principal Investigator: Rafael Pérez-Escamilla, Ph.D.
Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth
Disease/Condition: Beta-cell Function | Childhood Obesity | Impaired Glucose Tolerance | Insulin Resistance | Metabolic Syndrome | Pre-Diabetes
Principal Investigator: Sonia Caprio
T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs
Disease/Condition: Type 1 Diabetes Mellitus
Principal Investigator: Kevan Herold
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Disease/Condition: Autoantibody Positive | High Risk | Impaired Glucose Tolerance | Non-diabetic Relatives at Risk for Type 1 Diabetes
Principal Investigator: Kevan Herold
The Effect of Fatty Liver On Hepatic Gene Expression and Protein Activity
Disease/Condition: Obesity
Principal Investigator: Gerald Shulman
TODAY Genetics Study
Disease/Condition: Type 2 Diabetes
Principal Investigator: Sonia Caprio